People_

Dr Melissa Merritt

Senior Research Fellow
Stream Co-lead, Ovarian Cancer
The Daffodil Centre
Sydney School of Public Health
Faculty of Medicine and Health

Email

melissa.merritt@sydney.edu.au

Websites

The Daffodil Centre

Dept of Defense Ovarian Cancer Academy

Biographical details

Melissa Merritt is a cancer epidemiologist who trained in molecular biology, nutritional epidemiology and bioinformatics. She is currently a Senior Research Fellow and Co-Leader of the Ovarian Cancer research stream in the Daffodil Centre, a joint venture between Cancer Council New South Wales and the University of Sydney. In 2021 she was awarded an Ovarian Cancer Academy- Early Career Investigator Award from the US Department of Defense Ovarian Cancer Research Program. She received her PhD from The University of Queensland and a BSc with Honors (Class I) from James Cook University.

Research interests

Dr. Merritt's research program integrates molecular epidemiology, biomarkers for disease risk and progression and disparities research using data from epidemiological cohort studies and through participation in the Ovarian Cancer Cohort Consortium (OC3). Her current work focuses on: evaluating aspirin and non-aspirin NSAID use in relation to ovarian cancer survival in the OC3; studying biological pathways to help understand risk factor-disease associations; and investigating racial and ethic differences in risk factor associations for ovarian, endometrial and breast cancers.

Teaching and supervision

Dr. Merritt has taught several courses including Nutrition and Global Health (Harvard University, USA) and epidemiological courses (Principles and Methods of Epidemiology, Chronic Disease Epidemiology; Imperial College London, UK). She has also given specialist lectures focusing on epidemiology of ovarian, endometrial and breast cancers for postgraduate epidemiology students, medical students and health practitioners.

Current projects

Dr. Merritt's current work includes projects to:

Evaluate aspirin and non-aspirin NSAID use in relation to ovarian cancer survival in the ovarian cancer cohort consortium (OC3)
Study the role of the 27-hydroxycholesterol pathway in relation to endometrial cancer progression using endometrial cancer tumor tissues from the Hawaii Tumor Registry
Examine racial and ethnic differences in risk factors for ovarian cancer using data from ovarian cancer consortia datasets [the OC3 and the Ovarian Cancer Association Consortium (OCAC)]
https://daffodilcentre.org/streams/ovarian-cancer/

Awards and honours

Featured as an up and coming early/mid-career scientist in Nature publication’s “world at their feet” list: https://www.nature.com/articles/d41586-018-06622-8

Themes

Cancer, Reproductive, Maternal and Child Health

Keywords

Cancer, Epidemiology, Gynaecological cancer, Women's health, Biological markers

Approaches

Epidemiology, Prevention & Control, Risk Factors/Risk Assessment

International links

Japan	(National Cancer Center Institute for Cancer Control plus other institutions) I am a Co-Leader for the Reproductive Factors working group for the Asia Cohort Consortium
United Kingdom	(School of Public Health, Imperial College London) I spent four years as a Postdoctoral Research Fellow working with Marc Gunter and Elio Riboli on several projects focusing on dietary, reproductive and metabolic risk factors for ovarian and endometrial cancer using data from the European Prospective Investigation into Cancer and Nutrition (EPIC) study
United States	(Moffitt Cancer Center, plus other institutions) I am a steering committee member on the Ovarian Cancer Cohort Consortium (OC3) and am currently working on projects focusing on aspirin/NSAID use and ovarian cancer survival and racial and ethnic differences in relation to ovarian cancer risk
United States	(National Cancer Institute plus several international) I am an Associate Member Council Representative for the National Cancer Institute Cohort Consortium

Publications

By Type

Expand all

Journals

Abe, S., Choi, J., Katagiri, R., Mohammadi, Z., Shu, X., Wakai, K., Sawada, N., Ideno, Y., Tamakoshi, A., Seow, W., Merritt, M., et al (2024). Age at menarche by birth cohort: A pooled analysis of half a million women in Asia. Public Health, 237, 130-134. [More Information]
Yin, X., Choi, J., Shin, A., Katagiri, R., Shu, X., Sawada, N., Tamakoshi, A., Koh, W., Tsuji, I., Nagata, C., Merritt, M., et al (2024). Association between reproductive factors with lung cancer incidence and mortality: A pooled analysis of over 308,000 females in the Asia cohort consortium. International Journal of Cancer, 154(12), 2090-2105. [More Information]
Shin, A., Choi, J., Shu, X., Sawada, N., Tamakoshi, A., Koh, W., Sakata, R., Hozawa, A., Kim, J., Park, S., Merritt, M., et al (2024). Association of female reproductive and hormonal factors with gallbladder cancer risk in Asia: A pooled analysis of the Asia Cohort Consortium. International Journal of Cancer, 155(2), 240-250. [More Information]
Nabila, S., Shu, X., Sawada, N., Tamakoshi, A., Sakata, R., Hozawa, A., Kim, J., Nagata, C., Park, S., Kweon, S., Merritt, M., et al (2024). Differential patterns of reproductive and lifestyle risk factors for breast cancer according to birth cohorts among women in China, Japan and Korea. Breast Cancer Research, 26(1), 15. [More Information]
Arter, Z., Desmond, D., Berenberg, J., Killeen, J., Bunch, K., Merritt, M. (2024). Epithelial ovarian cancer survival by race and ethnicity in an equal-access healthcare population. British Journal of Cancer, 130(1), 108-113. [More Information]
Lacaze, P., Marquina, C., Tiller, J., Brotchie, A., Kang, Y., Merritt, M., Green, R., Watts, G., Nowak, K., Manchanda, R., Canfell, K., et al (2023). Combined population genomic screening for three high-risk conditions in Australia: a modelling study. EClinicalMedicine, 66. [More Information]
Frias-Gomez, J., Alemany, L., Benavente, Y., Clarke, M., de Francisco, J., De Vivo, I., Du, M., Goodman, M., Lacey, J., Liao, L., Merritt, M., et al (2023). Night shift work, sleep duration and endometrial cancer risk: A pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2). Sleep Medicine Reviews, 72. [More Information]
Desmond, D., Arter, Z., Berenberg, J., Killeen, J., Bunch, K., Merritt, M. (2023). Racial and ethnic differences in tumor characteristics among endometrial cancer patients in an equal-access healthcare population. Cancer Causes and Control, 34(11), 1017-1025. [More Information]
Katagiri, R., Iwasaki, M., Abe, S., Islam, M., Rahman, M., Saito, E., Merritt, M., Choi, J., Shin, A., Sawada, N., et al (2023). Reproductive Factors and Endometrial Cancer Risk Among Women. JAMA Network Open, 6(9), e2332296. [More Information]
Papadimitriou, N., Bouras, E., Van Den Brandt, P., Muller, D., Papadopoulou, A., Heath, A., Critselis, E., Gunter, M., Vineis, P., Ferrari, P., et al (2022). A Prospective Diet-Wide Association Study for Risk of Colorectal Cancer in EPIC. Clinical Gastroenterology and Hepatology, 20(4), 864-873.e13. [More Information]
Sarink, D., White, K., Loo, L., Wu, A., Wilkens, L., Le Marchand, L., Park, S., Setiawan, V., Merritt, M. (2022). Racial/ethnic differences in postmenopausal breast cancer risk by hormone receptor status: The multiethnic cohort study. International Journal of Cancer, 150(2), 221-231. [More Information]
Kaenkumchorn, T., Merritt, M., Lim, U., Le Marchand, L., Boushey, C., Shepherd, J., Wilkens, L., Ernst, T., Lampe, J. (2021). Diet and liver adiposity in older adults: The multiethnic cohort adiposity phenotype study. The Journal of Nutrition, 151(11), 3579-3587. [More Information]
Castro-Espin, C., Agudo, A., Bonet, C., Katzke, V., Fortner, R., Aleksandrova, K., Schulze, M., Tjønneland, A., Dahm, C., Quirós, J., et al (2021). Inflammatory potential of the diet and risk of breast cancer in the European Investigation into Cancer and Nutrition (EPIC) study. European Journal of Epidemiology, 36(9), 953-964. [More Information]
Dossus, L., Kouloura, E., Biessy, C., Viallon, V., Siskos, A., Dimou, N., Rinaldi, S., Merritt, M., Allen, N., Fortner, R., et al (2021). Prospective analysis of circulating metabolites and endometrial cancer risk. Gynecologic Oncology, 162(2), 475-481. [More Information]
Sarink, D., Wilkens, L., White, K., Le Marchand, L., Wu, A., Setiawan, V., Park, S., Park, S., Killeen, J., Merritt, M. (2021). Racial/ethnic differences in anthropometric and hormone-related factors and endometrial cancer risk: the Multiethnic Cohort Study. British Journal of Cancer, 124(10), 1724-1733. [More Information]
Merritt, M., Strickler, H., Hutson, A., Einstein, M., Rohan, T., Xue, X., Sherman, M., Brinton, L., Yu, H., Miller, D., et al (2021). Sex hormones, insulin, and insulin-like growth factors in recurrence of high-stage endometrial cancer. Cancer Epidemiology Biomarkers and Prevention, 30(4), 719-726. [More Information]
Fortner, R., Rice, M., Knutsen, S., Orlich, M., Visvanathan, K., Patel, A., Gaudet, M., Tjønneland, A., Kvaskoff, M., Kaaks, R., et al (2020). Ovarian cancer risk factor associations by primary anatomic site: The ovarian cancer cohort consortium. Cancer Epidemiology Biomarkers and Prevention, 29(10), 2010-2018. [More Information]
Sarink, D., Wu, A., Le Marchand, L., White, K., Park, S., Wendy Setiawan, V., Hernandez, B., Wilkens, L., Merritt, M. (2020). Racial/ethnic differences in ovarian cancer risk: Results from the multiethnic cohort study. Cancer Epidemiology Biomarkers and Prevention, 29(10), 2019-2025. [More Information]
Schwede, M., Waldron, L., Mok, S., Wei, W., Basunia, A., Merritt, M., Mitsiades, C., Parmigiani, G., Harrington, D., Quackenbush, J., et al (2020). The impact of stroma admixture on molecular subtypes and prognostic gene signatures in serous ovarian cancer. Cancer Epidemiology Biomarkers and Prevention, 29(2), 509-519. [More Information]
Nichols, H., Schoemaker, M., Cai, J., Xu, J., Wright, L., Brook, M., Jones, M., Adami, H., Baglietto, L., Bertrand, K., et al (2019). Breast cancer risk after recent childbirth: A pooled analysis of 15 prospective studies. Annals of Internal Medicine, 170(1), 22-30. [More Information]
Peres, L., Mallen, A., Townsend, M., Poole, E., Trabert, B., Allen, N., Arslan, A., Dossus, L., Fortner, R., Gram, I., et al (2019). High levels of C-reactive protein are associated with an increased risk of ovarian cancer: Results from the ovarian cancer Cohort Consortium. Cancer Research, 79(20), 5442-5451. [More Information]
Cramer, D., Fichorova, R., Terry, K., Yamamoto, H., Vitonis, A., Aune, D., Boeing, H., Brandstedt, J., Boutron-Ruault, M., Dorronsoro, M., et al (2018). Anti-CA15.3 and Anti-CA125 Antibodies and ovarian cancer risk: Results from the EPIC cohort. Cancer Epidemiology Biomarkers and Prevention, 27(7), 790-804. [More Information]
Jung, S., Allen, N., Arslan, A., Baglietto, L., Barricarte, A., Brinton, L., Egleston, B., Falk, R., Fortner, R., Helzlsouer, K., et al (2018). Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts. International Journal of Cancer, 142(2), 262-270. [More Information]
Schoemaker, M., Nichols, H., Wright, L., Brook, M., Jones, M., O'Brien, K., Adami, H., Baglietto, L., Bernstein, L., Bertrand, K., et al (2018). Association of Body Mass Index and Age with Subsequent Breast Cancer Risk in Premenopausal Women. JAMA Oncology, 4(11), e181771. [More Information]
Merritt, M., Rice, M., Barnard, M., Hankinson, S., Matulonis, U., Poole, E., Tworoger, S. (2018). Pre-diagnosis and post-diagnosis use of common analgesics and ovarian cancer prognosis (NHS/NHSII): a cohort study. The Lancet Oncology, 19(8), 1107-1116. [More Information]
Ose, J., Poole, E., Schock, H., Lehtinen, M., Arslan, A., Zeleniuch-Jacquotte, A., Visvanathan, K., Helzlsouer, K., Buring, J., Lee, I., et al (2017). Androgens are differentially associated with ovarian cancer subtypes in the Ovarian Cancer Cohort Consortium. Cancer Research, 77(14), 3951-3960. [More Information]
Fortner, R., Schock, H., Jung, S., Allen, N., Arslan, A., Brinton, L., Egleston, B., Falk, R., Gunter, M., Helzlsouer, K., et al (2017). Anti-Mullerian hormone and endometrial cancer: A multi-cohort study. British Journal of Cancer, 117(9), 1412-1418. [More Information]
Jung, S., Allen, N., Arslan, A., Baglietto, L., Brinton, L., Egleston, B., Falk, R., Fortner, R., Helzlsouer, K., Idahl, A., et al (2017). Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal women. Fertility and Sterility, 107(4), 1012-1022.e2. [More Information]
Ose, J., Schock, H., Poole, E., Lehtinen, M., Visvanathan, K., Helzlsouer, K., Buring, J., Lee, I., Tjønneland, A., Boutron-Ruault, M., et al (2017). Pre-diagnosis insulin-like growth factor-I and risk of epithelial invasive ovarian cancer by histological subtypes: A collaborative re-analysis from the Ovarian Cancer Cohort Consortium. Cancer Causes and Control, 28(5), 429-435. [More Information]
Sawada, N., Wark, P., Merritt, M., Tsugane, S., Ward, H., Rinaldi, S., Weiderpass, E., Dartois, L., His, M., Boutron-Ruault, M., et al (2017). The association between adult attained height and sitting height with mortality in the European prospective investigation into cancer and nutrition (EPIC). PloS One, 12(3), e0173117. [More Information]
Obõn-Santacana, M., Freisling, H., Peeters, P., Lujan-Barroso, L., Ferrari, P., Boutron-Ruault, M., Mesrine, S., Baglietto, L., Fortner, R., Katzke, V., et al (2016). Acrylamide and glycidamide hemoglobin adduct levels and endometrial cancer risk: A nested case-control study in nonsmoking postmenopausal women from the EPIC cohort. International Journal of Cancer, 138(5), 1129-1138. [More Information]
Obón-Santacana, M., Lujan-Barroso, L., Travis, R., Freisling, H., Ferrari, P., Severi, G., Baglietto, L., Boutron-Ruault, M., Fortner, R., Ose, J., et al (2016). Acrylamide and glycidamide hemoglobin adducts and epithelial ovarian cancer: A nested case-control study in nonsmoking postmenopausal women from the EPIC cohort. Cancer Epidemiology Biomarkers and Prevention, 25(1), 127-134. [More Information]
Merritt, M., Strickler, H., Einstein, M., Yang, H., Sherman, M., Wentzensen, N., Brouwer-Visser, J., Cossio, M., Whitney, K., Yu, H., et al (2016). Insulin/IGF and sex hormone axes in human endometrium and associations with endometrial cancer risk factors. Cancer Causes and Control, 27(6), 737-748. [More Information]
Merritt, M., Tzoulaki, I., Van Den Brandt, P., Schouten, L., Tsilidis, K., Weiderpass, E., Patel, C., Tjønneland, A., Hansen, L., Overvad, K., et al (2016). Nutrient-wide association study of 57 foods/nutrients and epithelial ovarian cancer in the European Prospective Investigation into Cancer and Nutrition study and the Netherlands Cohort Study. American Journal of Clinical Nutrition, 103(1), 161-167. [More Information]
Peters, S., van der Schouw, Y., Wood, A., Sweeting, M., Moons, K., Weiderpass, E., Arriola, L., Benetou, V., Boeing, H., Bonnet, F., et al (2016). Parity, breastfeeding and risk of coronary heart disease: A pan-European case-cohort study. European Journal of Preventive Cardiology, 23(16), 1755-1765. [More Information]
Li, K., Hüsing, A., Fortner, R., Tjønneland, A., Hansen, L., Dossus, L., Chang-Claude, J., Bergmann, M., Steffen, A., Bamia, C., et al (2015). An epidemiologic risk prediction model for ovarian cancer in Europe: The EPIC study. British Journal of Cancer, 112(7), 1257-1265. [More Information]
Ince, T., Sousa, A., Jones, M., Harrell, J., Agoston, E., Krohn, M., Selfors, L., Liu, W., Chen, K., Yong, M., et al (2015). Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours. Nature Communications, 6. [More Information]
Merritt, M., Gunter, M. (2015). Coffee Drinking and Endometrial Cancer. Current Nutrition Reports, 4(1), 40-46. [More Information]
Obón-Santacana, M., Peeters, P., Freisling, H., Dossus, L., Clavel-Chapelon, F., Baglietto, L., Schock, H., Fortner, R., Boeing, H., Tjønneland, A., et al (2015). Dietary intake of acrylamide and epithelial ovarian cancer risk in the european prospective investigation into cancer and nutrition (EPIC) cohort. Cancer Epidemiology Biomarkers and Prevention, 24(1), 291-297. [More Information]
Merritt, M., Tzoulaki, I., Tworoger, S., De Vivo, I., Hankinson, S., Fernandes, J., Tsilidis, K., Weiderpass, E., Tjønneland, A., Petersen, K., et al (2015). Investigation of dietary factors and endometrial cancer risk using a nutrient-wide association study approach in the EPIC and nurses' health study (NHS) and NHSII. Cancer Epidemiology Biomarkers and Prevention, 24(2), 466-471. [More Information]
Fortner, R., Ose, J., Merritt, M., Schock, H., Tjønneland, A., Hansen, L., Overvad, K., Dossus, L., Clavel-Chapelon, F., Baglietto, L., et al (2015). Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohort. International Journal of Cancer, 137(5), 1196-1208. [More Information]
Merritt, M., Riboli, E., Murphy, N., Kadi, M., Tjønneland, A., Olsen, A., Overvad, K., Dossus, L., Dartois, L., Clavel-Chapelon, F., et al (2015). Reproductive factors and risk of mortality in the European Prospective Investigation into Cancer and Nutrition; a cohort study. BMC Medicine, 13(1). [More Information]

show 39 more

By Year

Expand all

2024

Abe, S., Choi, J., Katagiri, R., Mohammadi, Z., Shu, X., Wakai, K., Sawada, N., Ideno, Y., Tamakoshi, A., Seow, W., Merritt, M., et al (2024). Age at menarche by birth cohort: A pooled analysis of half a million women in Asia. Public Health, 237, 130-134. [More Information]
Yin, X., Choi, J., Shin, A., Katagiri, R., Shu, X., Sawada, N., Tamakoshi, A., Koh, W., Tsuji, I., Nagata, C., Merritt, M., et al (2024). Association between reproductive factors with lung cancer incidence and mortality: A pooled analysis of over 308,000 females in the Asia cohort consortium. International Journal of Cancer, 154(12), 2090-2105. [More Information]
Shin, A., Choi, J., Shu, X., Sawada, N., Tamakoshi, A., Koh, W., Sakata, R., Hozawa, A., Kim, J., Park, S., Merritt, M., et al (2024). Association of female reproductive and hormonal factors with gallbladder cancer risk in Asia: A pooled analysis of the Asia Cohort Consortium. International Journal of Cancer, 155(2), 240-250. [More Information]
Nabila, S., Shu, X., Sawada, N., Tamakoshi, A., Sakata, R., Hozawa, A., Kim, J., Nagata, C., Park, S., Kweon, S., Merritt, M., et al (2024). Differential patterns of reproductive and lifestyle risk factors for breast cancer according to birth cohorts among women in China, Japan and Korea. Breast Cancer Research, 26(1), 15. [More Information]
Arter, Z., Desmond, D., Berenberg, J., Killeen, J., Bunch, K., Merritt, M. (2024). Epithelial ovarian cancer survival by race and ethnicity in an equal-access healthcare population. British Journal of Cancer, 130(1), 108-113. [More Information]

show 2 more

2023

Lacaze, P., Marquina, C., Tiller, J., Brotchie, A., Kang, Y., Merritt, M., Green, R., Watts, G., Nowak, K., Manchanda, R., Canfell, K., et al (2023). Combined population genomic screening for three high-risk conditions in Australia: a modelling study. EClinicalMedicine, 66. [More Information]
Frias-Gomez, J., Alemany, L., Benavente, Y., Clarke, M., de Francisco, J., De Vivo, I., Du, M., Goodman, M., Lacey, J., Liao, L., Merritt, M., et al (2023). Night shift work, sleep duration and endometrial cancer risk: A pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2). Sleep Medicine Reviews, 72. [More Information]
Desmond, D., Arter, Z., Berenberg, J., Killeen, J., Bunch, K., Merritt, M. (2023). Racial and ethnic differences in tumor characteristics among endometrial cancer patients in an equal-access healthcare population. Cancer Causes and Control, 34(11), 1017-1025. [More Information]
Katagiri, R., Iwasaki, M., Abe, S., Islam, M., Rahman, M., Saito, E., Merritt, M., Choi, J., Shin, A., Sawada, N., et al (2023). Reproductive Factors and Endometrial Cancer Risk Among Women. JAMA Network Open, 6(9), e2332296. [More Information]

show 1 more

2022

Papadimitriou, N., Bouras, E., Van Den Brandt, P., Muller, D., Papadopoulou, A., Heath, A., Critselis, E., Gunter, M., Vineis, P., Ferrari, P., et al (2022). A Prospective Diet-Wide Association Study for Risk of Colorectal Cancer in EPIC. Clinical Gastroenterology and Hepatology, 20(4), 864-873.e13. [More Information]
Sarink, D., White, K., Loo, L., Wu, A., Wilkens, L., Le Marchand, L., Park, S., Setiawan, V., Merritt, M. (2022). Racial/ethnic differences in postmenopausal breast cancer risk by hormone receptor status: The multiethnic cohort study. International Journal of Cancer, 150(2), 221-231. [More Information]

2021

Kaenkumchorn, T., Merritt, M., Lim, U., Le Marchand, L., Boushey, C., Shepherd, J., Wilkens, L., Ernst, T., Lampe, J. (2021). Diet and liver adiposity in older adults: The multiethnic cohort adiposity phenotype study. The Journal of Nutrition, 151(11), 3579-3587. [More Information]
Castro-Espin, C., Agudo, A., Bonet, C., Katzke, V., Fortner, R., Aleksandrova, K., Schulze, M., Tjønneland, A., Dahm, C., Quirós, J., et al (2021). Inflammatory potential of the diet and risk of breast cancer in the European Investigation into Cancer and Nutrition (EPIC) study. European Journal of Epidemiology, 36(9), 953-964. [More Information]
Dossus, L., Kouloura, E., Biessy, C., Viallon, V., Siskos, A., Dimou, N., Rinaldi, S., Merritt, M., Allen, N., Fortner, R., et al (2021). Prospective analysis of circulating metabolites and endometrial cancer risk. Gynecologic Oncology, 162(2), 475-481. [More Information]
Sarink, D., Wilkens, L., White, K., Le Marchand, L., Wu, A., Setiawan, V., Park, S., Park, S., Killeen, J., Merritt, M. (2021). Racial/ethnic differences in anthropometric and hormone-related factors and endometrial cancer risk: the Multiethnic Cohort Study. British Journal of Cancer, 124(10), 1724-1733. [More Information]
Merritt, M., Strickler, H., Hutson, A., Einstein, M., Rohan, T., Xue, X., Sherman, M., Brinton, L., Yu, H., Miller, D., et al (2021). Sex hormones, insulin, and insulin-like growth factors in recurrence of high-stage endometrial cancer. Cancer Epidemiology Biomarkers and Prevention, 30(4), 719-726. [More Information]

show 2 more

2020

Fortner, R., Rice, M., Knutsen, S., Orlich, M., Visvanathan, K., Patel, A., Gaudet, M., Tjønneland, A., Kvaskoff, M., Kaaks, R., et al (2020). Ovarian cancer risk factor associations by primary anatomic site: The ovarian cancer cohort consortium. Cancer Epidemiology Biomarkers and Prevention, 29(10), 2010-2018. [More Information]
Sarink, D., Wu, A., Le Marchand, L., White, K., Park, S., Wendy Setiawan, V., Hernandez, B., Wilkens, L., Merritt, M. (2020). Racial/ethnic differences in ovarian cancer risk: Results from the multiethnic cohort study. Cancer Epidemiology Biomarkers and Prevention, 29(10), 2019-2025. [More Information]
Schwede, M., Waldron, L., Mok, S., Wei, W., Basunia, A., Merritt, M., Mitsiades, C., Parmigiani, G., Harrington, D., Quackenbush, J., et al (2020). The impact of stroma admixture on molecular subtypes and prognostic gene signatures in serous ovarian cancer. Cancer Epidemiology Biomarkers and Prevention, 29(2), 509-519. [More Information]

2019

Nichols, H., Schoemaker, M., Cai, J., Xu, J., Wright, L., Brook, M., Jones, M., Adami, H., Baglietto, L., Bertrand, K., et al (2019). Breast cancer risk after recent childbirth: A pooled analysis of 15 prospective studies. Annals of Internal Medicine, 170(1), 22-30. [More Information]
Peres, L., Mallen, A., Townsend, M., Poole, E., Trabert, B., Allen, N., Arslan, A., Dossus, L., Fortner, R., Gram, I., et al (2019). High levels of C-reactive protein are associated with an increased risk of ovarian cancer: Results from the ovarian cancer Cohort Consortium. Cancer Research, 79(20), 5442-5451. [More Information]

2018

Cramer, D., Fichorova, R., Terry, K., Yamamoto, H., Vitonis, A., Aune, D., Boeing, H., Brandstedt, J., Boutron-Ruault, M., Dorronsoro, M., et al (2018). Anti-CA15.3 and Anti-CA125 Antibodies and ovarian cancer risk: Results from the EPIC cohort. Cancer Epidemiology Biomarkers and Prevention, 27(7), 790-804. [More Information]
Jung, S., Allen, N., Arslan, A., Baglietto, L., Barricarte, A., Brinton, L., Egleston, B., Falk, R., Fortner, R., Helzlsouer, K., et al (2018). Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts. International Journal of Cancer, 142(2), 262-270. [More Information]
Schoemaker, M., Nichols, H., Wright, L., Brook, M., Jones, M., O'Brien, K., Adami, H., Baglietto, L., Bernstein, L., Bertrand, K., et al (2018). Association of Body Mass Index and Age with Subsequent Breast Cancer Risk in Premenopausal Women. JAMA Oncology, 4(11), e181771. [More Information]
Merritt, M., Rice, M., Barnard, M., Hankinson, S., Matulonis, U., Poole, E., Tworoger, S. (2018). Pre-diagnosis and post-diagnosis use of common analgesics and ovarian cancer prognosis (NHS/NHSII): a cohort study. The Lancet Oncology, 19(8), 1107-1116. [More Information]

show 1 more

2017

Ose, J., Poole, E., Schock, H., Lehtinen, M., Arslan, A., Zeleniuch-Jacquotte, A., Visvanathan, K., Helzlsouer, K., Buring, J., Lee, I., et al (2017). Androgens are differentially associated with ovarian cancer subtypes in the Ovarian Cancer Cohort Consortium. Cancer Research, 77(14), 3951-3960. [More Information]
Fortner, R., Schock, H., Jung, S., Allen, N., Arslan, A., Brinton, L., Egleston, B., Falk, R., Gunter, M., Helzlsouer, K., et al (2017). Anti-Mullerian hormone and endometrial cancer: A multi-cohort study. British Journal of Cancer, 117(9), 1412-1418. [More Information]
Jung, S., Allen, N., Arslan, A., Baglietto, L., Brinton, L., Egleston, B., Falk, R., Fortner, R., Helzlsouer, K., Idahl, A., et al (2017). Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal women. Fertility and Sterility, 107(4), 1012-1022.e2. [More Information]
Ose, J., Schock, H., Poole, E., Lehtinen, M., Visvanathan, K., Helzlsouer, K., Buring, J., Lee, I., Tjønneland, A., Boutron-Ruault, M., et al (2017). Pre-diagnosis insulin-like growth factor-I and risk of epithelial invasive ovarian cancer by histological subtypes: A collaborative re-analysis from the Ovarian Cancer Cohort Consortium. Cancer Causes and Control, 28(5), 429-435. [More Information]
Sawada, N., Wark, P., Merritt, M., Tsugane, S., Ward, H., Rinaldi, S., Weiderpass, E., Dartois, L., His, M., Boutron-Ruault, M., et al (2017). The association between adult attained height and sitting height with mortality in the European prospective investigation into cancer and nutrition (EPIC). PloS One, 12(3), e0173117. [More Information]

show 2 more

2016

Obõn-Santacana, M., Freisling, H., Peeters, P., Lujan-Barroso, L., Ferrari, P., Boutron-Ruault, M., Mesrine, S., Baglietto, L., Fortner, R., Katzke, V., et al (2016). Acrylamide and glycidamide hemoglobin adduct levels and endometrial cancer risk: A nested case-control study in nonsmoking postmenopausal women from the EPIC cohort. International Journal of Cancer, 138(5), 1129-1138. [More Information]
Obón-Santacana, M., Lujan-Barroso, L., Travis, R., Freisling, H., Ferrari, P., Severi, G., Baglietto, L., Boutron-Ruault, M., Fortner, R., Ose, J., et al (2016). Acrylamide and glycidamide hemoglobin adducts and epithelial ovarian cancer: A nested case-control study in nonsmoking postmenopausal women from the EPIC cohort. Cancer Epidemiology Biomarkers and Prevention, 25(1), 127-134. [More Information]
Merritt, M., Strickler, H., Einstein, M., Yang, H., Sherman, M., Wentzensen, N., Brouwer-Visser, J., Cossio, M., Whitney, K., Yu, H., et al (2016). Insulin/IGF and sex hormone axes in human endometrium and associations with endometrial cancer risk factors. Cancer Causes and Control, 27(6), 737-748. [More Information]
Merritt, M., Tzoulaki, I., Van Den Brandt, P., Schouten, L., Tsilidis, K., Weiderpass, E., Patel, C., Tjønneland, A., Hansen, L., Overvad, K., et al (2016). Nutrient-wide association study of 57 foods/nutrients and epithelial ovarian cancer in the European Prospective Investigation into Cancer and Nutrition study and the Netherlands Cohort Study. American Journal of Clinical Nutrition, 103(1), 161-167. [More Information]
Peters, S., van der Schouw, Y., Wood, A., Sweeting, M., Moons, K., Weiderpass, E., Arriola, L., Benetou, V., Boeing, H., Bonnet, F., et al (2016). Parity, breastfeeding and risk of coronary heart disease: A pan-European case-cohort study. European Journal of Preventive Cardiology, 23(16), 1755-1765. [More Information]

show 2 more

2015

Li, K., Hüsing, A., Fortner, R., Tjønneland, A., Hansen, L., Dossus, L., Chang-Claude, J., Bergmann, M., Steffen, A., Bamia, C., et al (2015). An epidemiologic risk prediction model for ovarian cancer in Europe: The EPIC study. British Journal of Cancer, 112(7), 1257-1265. [More Information]
Ince, T., Sousa, A., Jones, M., Harrell, J., Agoston, E., Krohn, M., Selfors, L., Liu, W., Chen, K., Yong, M., et al (2015). Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours. Nature Communications, 6. [More Information]
Merritt, M., Gunter, M. (2015). Coffee Drinking and Endometrial Cancer. Current Nutrition Reports, 4(1), 40-46. [More Information]
Obón-Santacana, M., Peeters, P., Freisling, H., Dossus, L., Clavel-Chapelon, F., Baglietto, L., Schock, H., Fortner, R., Boeing, H., Tjønneland, A., et al (2015). Dietary intake of acrylamide and epithelial ovarian cancer risk in the european prospective investigation into cancer and nutrition (EPIC) cohort. Cancer Epidemiology Biomarkers and Prevention, 24(1), 291-297. [More Information]
Merritt, M., Tzoulaki, I., Tworoger, S., De Vivo, I., Hankinson, S., Fernandes, J., Tsilidis, K., Weiderpass, E., Tjønneland, A., Petersen, K., et al (2015). Investigation of dietary factors and endometrial cancer risk using a nutrient-wide association study approach in the EPIC and nurses' health study (NHS) and NHSII. Cancer Epidemiology Biomarkers and Prevention, 24(2), 466-471. [More Information]
Fortner, R., Ose, J., Merritt, M., Schock, H., Tjønneland, A., Hansen, L., Overvad, K., Dossus, L., Clavel-Chapelon, F., Baglietto, L., et al (2015). Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohort. International Journal of Cancer, 137(5), 1196-1208. [More Information]
Merritt, M., Riboli, E., Murphy, N., Kadi, M., Tjønneland, A., Olsen, A., Overvad, K., Dossus, L., Dartois, L., Clavel-Chapelon, F., et al (2015). Reproductive factors and risk of mortality in the European Prospective Investigation into Cancer and Nutrition; a cohort study. BMC Medicine, 13(1). [More Information]

show 4 more

Selected Grants

2024

Ovarian Cancer Research Stream, Merritt M, Cancer Council NSW/Research Grant
Modelling the role of opportunistic salpingectomy to lower Australian ovarian cancer incidence, Merritt M, Tour de Cure Ltd/Prevention Research Grant
Immunophenotypes and use of aspirin or NSAIDs in ovarian cancer patients (pilot study supplement to 'Aspirin and NSAID use and ovarian cancer prognosis: a molecular epidemiological study'), Merritt M, Laniti D, US Department of Defence (USA)/Research Support

2022

Aspirin and NSAID Use and Ovarian Cancer Prognosis: a Molecular Epidemiological Study, Merritt M, US Department of Defence (USA)/Ovarian Cancer Research Program

Page not found

Dr Melissa Merritt

Publications

By Type

By Year

Selected Grants

2024

2022